zadnja posodobitev :
19/11/2024
Infostab
Seznami
Seznami
Poiščite združljivosti
Tabela združljivosti Y-strani
Viri
raziskovalne skupine
valistab
poster
Povezave
sponzorji
Avtor
Navodilo za uporabo
Newsletter
Epirubicin hydrochloride
Kemična formula
Lastniško ime
Sestava pomožnih snovi je med paralelami lahko različna
Anthracine
Malezija
Axirubicine
Nemčija
Bendaepi
Nemčija
Binarin
Mehika
Bioepycina
Poljska
Crisabon
Argentina
Cuatroepi
Argentina
Ecclepia
Romunija
Elebicin
Mehika
Ellence
Združene države Amerike
Epi Cell
Nemčija
Epidoxo
Argentina, Čile, Venezuela
Epifil
Ekvador
Epilem
Kolumbija, Mehika
Epimedac
Nemčija
Epirubicin
Avstralija, Avstrija, Belgija, Danska, Islandija, Madžarska, nova Zelandija, Savdska Arabija, Švedska, Švica, Turčija, Velika Britanija
Epirubicina
Argentina, Ekvador, Kolumbija, Mehika, Romunija, Španija
Epirubicine
Belgija, Francija, Švica
Farmarubicin
Turčija
Farmorubicin
Avstrija, Brazilija, Danska, Finska, Grčija, Norveška, Savdska Arabija, Švedska, Švica
Farmorubicin CSV
Južnoafriška republika
Farmorubicin PFS
Hrvaška, Poljska, Slovenija
Farmorubicin RD
Brazilija, Poljska, ruščina, Švica
Farmorubicin RTU
Nizozemska
Farmorubicina
Brazilija, Italija, Portugalska, Španija
Farmorubicine
Belgija, Francija
Pharmorubicin
Velika Britanija
Viri : Epirubicin hydrochloride
Tip
objava
148
časopis
Dine T, Cazin JC, Gressier B, Luycks M, Brunet C, Cazin M, Goudaliez F, Mallevais ML, Toraub I.
Stability and compatibility of four anthracyclines: doxorubicin, epirubicin, daunorubicin and pirarubicin with PVC infusion bags.
Pharm Weekbl [Sci] 1992 ; 14: 365-369.
525
časopis
De Vroe C, De Muynck C, Remon JP, Samsom M.
A study on the stability of three antineoplastic drugs and on their sorption by IV delivery systems and end-line filters.
Int J Pharm 1990 ; 65: 49-56.
683
časopis
Walker SE, Lau DWC, DeAngelis C, Iazetta J, Coons C.
Epirubicin stability in syringes and glass vials and evaluation of chemical contamination.
Can J Hosp Pharm 1990 ; 43: 265-272.
686
časopis
Wood MJ, Irwin WJ, Scott DK.
Stability of doxorubicin, daunorubicin and epirubicin in plastic syringes and minibags.
J Clin Pharm Ther 1990 ; 15: 279-289.
887
časopis
Pujol M, Munoz M, Prat J, Giona V, De Bolos J.
Stability study of epirubicin in NaCl 0.9% injection.
Ann Pharmacotherapy 1997 ; 31: 992-995.
1237
časopis
Keusters L, Stolk LML, Umans R, Van Asten P.
Stability of solutions of doxorubicin and epirubicin in plastic minibags for intravesical use after storage at -20°C and thawing by microwave radiation.
Pharm Weekbl [Sci] 1986 ; 8: 194-197.
1265
časopis
Wood MJ, Irwin WJ, Scott DK.
Photodegradation of doxorubicin, daunorubicin and epirubicin measured by high-performance liquid chromatography.
J Clin Pharm Ther 1990 ; 15: 291-300.
1317
časopis
Adams PS, Haines-Hutt RF, Bradford E, Palmer A, Rowland CG.
Pharmaceutical aspects of home infusion therapy for cancer patients.
Pharm J 1987 ; 238: 476-478.
1662
časopis
Trissel LA, Saenz CA, Ingram DS, Ogundele AB.
Compatibility screening of oxaliplatin during simulated Y-site administration with other drugs.
J Oncol Pharm Practice 2002 ; 8: 33-37.
1823
časopis
Sewell GJ, Rigby-Jones AE, Priston MJ.
Stability of intravesical epirubicin infusion: a sequential temperature study.
J Clin Pharm Ther 2003 ; 28: 349-353.
1897
časopis
Sautou-Miranda V, Brigas F, Thibault M, Chopineau J.
Compatibility of doxorubicin, daunorubicin and epirubicin with low-density polyethylene and polyvinyl chloride, and stability in various conditions of storage.
EJHP 2001 ; 7, 3: 108-115.
1955
časopis
Trissel LA, Zhang Y.
Palonosetron HCl compatibility and stability with doxorubicin HCl and epirubicin HCl during simulated Y-site administration.
Ann Pharmacotherapy 2005 ; 39: 280-283.
2168
časopis
Ozdemir FA, Anilanmert B, Pekin M.
Spectrophotometric investigation of the chemical compatibility of the anticancer irinotecan-HCl and epirubicin-HCl in the same infusion solution.
Cancer Chemother Pharmacol 2005 ; 56, 5: 529-534.
2257
Traduction Laboratorij
Stability of epirubicin "Ebewe" infusion solutions.
Ebewe Pharma 2007
3473
časopis
Bennis Y, Savry A, Correard F, Montana M, Sauzet C, Gauthier-Villano L, Pisano P, Pourroy B.
Stability of a highly concentrated solution of epirubicin for conventional transcatheter arterial chemoembolization.
Int J Pharm 2015 ; 495, 2: 956-962.
3474
Traduction Laboratorij
Fluorouracil - Summary of Product Characteristics
Accord Healthcare Limited 2009
3632
Traduction Laboratorij
Epirubicine (Epirubicine Hospira®) - Summary of Product Characteristics
Hospira 2017
3670
časopis
Sewell G, Massimini M.
Studies on the stability and compatibility of cytotoxic drug infusion with the Tevadaptor system.
EJOP 2014 ; 8, 3: 26-30.
3708
poster
Sarakbi I, Thiesen J, Krämer I.
Compatibility of epirubicin-loaded DC Beads with different contrast media.
ECOP 2 Krakow 2014
3918
časopis
Sarakbi I, Krämer I.
Compatibility of epirubicin-loaded DC bead™ with different non-ionic contrast media.
J Oncol Pharm Practice 2016 ; 22: 749-756.
4352
časopis
Li J, Yao C, Xu Y, Ping P, Yin H, Sun Y.
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
J Clin Pharm Ther 2019 ; 44: 875-882.
Mentions Légales